Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
Clinical trial NCT04042051 · TERMINATED
Trial details
- NCT number
- NCT04042051
- Sponsor
- Cancer Trials Ireland
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-12
- Primary completion
- 2020-11-02
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.